Published in Br J Pharmacol on November 01, 1974
The uptake of [3H]GABA by slices of rat cerebral cortex. J Neurochem (1968) 5.05
GABA uptake in rat central nervous system: comparison of uptake in slices and homogenates and the effects of some inhibitors. J Neurochem (1971) 2.00
A simple apparatus for studying the release of neurotransmitters from synaptosomes. Eur J Pharmacol (1974) 1.91
Synaptic biochemistry of amino acids. Fed Proc (1973) 1.74
Glycine uptake in rat central nervous system slices and homogenates: evidence for different uptake systems in spinal cord and cerebral cortex. J Neurochem (1971) 1.24
Detectability of high and low affinity uptake systems for GABA and glutamate in rat brain slices and synaptosomes. Life Sci I (1973) 1.03
Regional differences in the synaptosomal uptake of 3H-gamma-aminobutyric acid and 14C-glutamate and possible role of exchange processes. J Pharmacol Exp Ther (1974) 0.87
Krox-20 controls myelination in the peripheral nervous system. Nature (1994) 4.04
A novel endothelial-specific membrane protein is a marker of cell-cell contacts. J Cell Biol (1992) 3.85
Craniofacial, vestibular and bone defects in mice lacking the Distal-less-related gene Dlx5. Development (1999) 2.48
Disruption of Krox-20 results in alteration of rhombomeres 3 and 5 in the developing hindbrain. Cell (1993) 2.17
International Union of Pharmacology. XXXIII. Mammalian gamma-aminobutyric acid(B) receptors: structure and function. Pharmacol Rev (2002) 2.15
Predominant contribution of IgA antibody-forming cells to an immune response detected in extraintestinal lymphoid tissues of germ-free mice exposed to antigen by the oral route. J Immunol (1970) 2.06
Selective release of glutamate from cerebellar granule cells differentiating in culture. Proc Natl Acad Sci U S A (1982) 1.92
Microglia as effector cells in brain damage and repair: focus on prostanoids and nitric oxide. Prog Neurobiol (1998) 1.91
A simple apparatus for studying the release of neurotransmitters from synaptosomes. Eur J Pharmacol (1974) 1.91
Multiple pituitary and ovarian defects in Krox-24 (NGFI-A, Egr-1)-targeted mice. Mol Endocrinol (1998) 1.62
Production of hemolymphopoietic cytokines (IL-6, IL-8, colony-stimulating factors) by normal human astrocytes in response to IL-1 beta and tumor necrosis factor-alpha. J Immunol (1992) 1.59
Isolation and physicochemical characterization of electrolectin, a beta-D-galactoside binding lectin from the electric organ of Electrophorus electricus. J Biol Chem (1981) 1.57
Autoradiographic localization and depolarization-induced release of acidic amino acids in differentiating cerebellar granule cell cultures. Brain Res (1984) 1.56
Altered expression of neuronal cell adhesion molecules induced by nerve injury and repair. J Cell Biol (1986) 1.56
Polyethylenimine-based intravenous delivery of transgenes to mouse lung. Gene Ther (1998) 1.45
Role of the peroxisome proliferator-activated receptor-gamma (PPAR-gamma) and its natural ligand 15-deoxy-Delta12, 14-prostaglandin J2 in the regulation of microglial functions. Eur J Neurosci (2000) 1.44
Role of Dlx6 in regulation of an endothelin-1-dependent, dHAND branchial arch enhancer. Genes Dev (2001) 1.40
Differential distribution of cell adhesion molecules during histogenesis of the chick nervous system. J Neurosci (1986) 1.38
Multiple functions of Dlx genes. Int J Dev Biol (2000) 1.35
Size, diffusibility and transfection performance of linear PEI/DNA complexes in the mouse central nervous system. Gene Ther (1998) 1.32
Decreased heart rate variability in patients with chronic obstructive pulmonary disease. Chest (1994) 1.28
Presynaptic kynurenate-sensitive receptors inhibit glutamate release. Eur J Neurosci (2001) 1.27
Reversible inhibitory effects of interferon-gamma and tumour necrosis factor-alpha on oligodendroglial lineage cell proliferation and differentiation in vitro. Eur J Neurosci (1996) 1.25
Microdialysis in Parkinsonian patient basal ganglia: acute apomorphine-induced clinical and electrophysiological effects not paralleled by changes in the release of neuroactive amino acids. Exp Neurol (2001) 1.25
Heterogeneity of presynaptic muscarinic receptors regulating neurotransmitter release in the rat brain. J Pharmacol Exp Ther (1984) 1.22
Carrier-mediated release of neurotransmitters. Trends Neurosci (1993) 1.22
Effect of sympathomimetic amines on the synaptosomal transport of noradrenaline, dopamine and 5-hydroxytryptamine. Eur J Pharmacol (1977) 1.21
Multiple GABAB receptors. Trends Pharmacol Sci (1993) 1.21
Differential regulation of the zinc finger genes Krox-20 and Krox-24 (Egr-1) suggests antagonistic roles in Schwann cells. J Neurosci Res (1997) 1.19
Targeted inhibition of gene expression of pancreatitis-associated proteins exacerbates the severity of acute pancreatitis in rats. Scand J Gastroenterol (2004) 1.15
Synaptosomes still viable after 25 years of superfusion. Neurochem Res (2000) 1.13
Isoprostanes, novel markers of oxidative injury, help understanding the pathogenesis of neurodegenerative diseases. Neurochem Res (2000) 1.12
Astrocyte cultures from human embryonic brain: characterization and modulation of surface molecules by inflammatory cytokines. J Neurosci Res (1992) 1.12
Induction of prostanoid biosynthesis by bacterial lipopolysaccharide and isoproterenol in rat microglial cultures. J Neurochem (1995) 1.11
Executive function impairment in early-treated PKU subjects with normal mental development. J Inherit Metab Dis (2004) 1.09
Dopamine can be released by two mechanisms differentially affected by the dopamine transport inhibitor nomifensine. J Pharmacol Exp Ther (1979) 1.07
The costimulatory molecule B7 is expressed on human microglia in culture and in multiple sclerosis acute lesions. J Neuropathol Exp Neurol (1995) 1.06
Relationship between mevalonate pathway and arterial myocyte proliferation: in vitro studies with inhibitors of HMG-CoA reductase. Atherosclerosis (1993) 1.06
Rapid crossing of the pulmonary endothelial barrier by polyethylenimine/DNA complexes. Gene Ther (2000) 1.05
CGP 52432: a novel potent and selective GABAB autoreceptor antagonist in rat cerebral cortex. Eur J Pharmacol (1993) 1.05
Bipotential precursors of putative fibrous astrocytes and oligodendrocytes in rat cerebellar cultures express distinct surface features and "neuron-like" gamma-aminobutyric acid transport. Proc Natl Acad Sci U S A (1986) 1.04
In vivo studies of the cerebral glutamate receptor/NO/cGMP pathway. Prog Neurobiol (1999) 1.03
Cholinergic terminals in rat hippocampus possess 5-HT1B receptors mediating inhibition of acetylcholine release. Eur J Pharmacol (1986) 1.03
Comparative study of the effects of mianserin, a tetracyclic antidepressant, and of imipramine on uptake and release of neurotransmitters in synaptosomes. J Pharm Pharmacol (1976) 1.03
Detectability of high and low affinity uptake systems for GABA and glutamate in rat brain slices and synaptosomes. Life Sci I (1973) 1.03
Nerve growth factor and brain-derived neurotrophic factor increase neurotransmitter release in the rat visual cortex. Eur J Neurosci (1998) 1.03
Establishment, characterization, and evolution of cultures enriched in type-2 astrocytes. J Neurosci Res (1989) 1.02
Release and exchange studies relating to the synaptosomal uptake of GABA. J Neurochem (1975) 1.02
Interferon gamma gene expression in rat central nervous system glial cells. Cytokine (1998) 1.02
Opposite effects of interferon-gamma and prostaglandin E2 on tumor necrosis factor and interleukin-10 production in microglia: a regulatory loop controlling microglia pro- and anti-inflammatory activities. J Neurosci Res (1999) 1.01
Prevention and therapy with electrolectin of experimental autoimmune myasthenia gravis in rabbits. Eur J Immunol (1983) 1.01
Progressive activation of adult microglial cells in vitro. Glia (1996) 1.00
Case report. Adrenocortical oncocytoma: CT and MRI findings. J Comput Assist Tomogr (1996) 1.00
Up-regulation of cyclooxygenase-2 expression in cultured microglia by prostaglandin E2, cyclic AMP and non-steroidal anti-inflammatory drugs. Eur J Neurosci (1997) 0.99
Analysis of B7-1 and B7-2 costimulatory ligands in cultured mouse microglia: upregulation by interferon-gamma and lipopolysaccharide and downregulation by interleukin-10, prostaglandin E2 and cyclic AMP-elevating agents. J Neuroimmunol (1997) 0.99
Neurotoxicity of HIV coat protein gp120, NMDA receptors, and protein kinase C: a study with rat cerebellar granule cell cultures. J Neurosci Res (1993) 0.98
Serotonin release is modulated by presynaptic autoreceptors. Eur J Pharmacol (1979) 0.98
Neurochemical and autonomic pharmacological profiles of the 6-aza-analogue of mianserin, Org 3770 and its enantiomers. Neuropharmacology (1988) 0.97
Two different ionotropic receptors are activated by ATP in rat microglia. J Physiol (1999) 0.97
Exchange of neurotransmitter amino acid at nerve endings can simulate high affinity uptake. Nature (1974) 0.96
Human immunodeficiency virus type 1 Tat protein stimulates inducible nitric oxide synthase expression and nitric oxide production in microglial cultures. J Neuropathol Exp Neurol (1999) 0.96
Functional evidence for multiple gamma-aminobutyric acidB receptor subtypes in the rat cerebral cortex. J Pharmacol Exp Ther (1992) 0.96
Adult neural stem cell cycling in vivo requires thyroid hormone and its alpha receptor. FASEB J (2005) 0.95
Pharmacologically distinct GABAB receptors that mediate inhibition of GABA and glutamate release in human neocortex. Br J Pharmacol (1997) 0.95
Synergistic stimulation of MHC class I and IRF-1 gene expression by IFN-gamma and TNF-alpha in oligodendrocytes. Eur J Neurosci (1998) 0.95
Is there a functional linkage between neurotransmitter uptake mechanisms and presynaptic receptors? J Pharmacol Exp Ther (1984) 0.95
Down-regulation of microglial cyclo-oxygenase-2 and inducible nitric oxide synthase expression by lipocortin 1. Br J Pharmacol (1999) 0.94
Increased brain synthesis of prostaglandin E2 and F2-isoprostane in human and experimental transmissible spongiform encephalopathies. J Neuropathol Exp Neurol (2000) 0.94
Interaction acetylcholine-glutamate in rat hippocampus: involvement of two subtypes of M-2 muscarinic receptors. J Pharmacol Exp Ther (1989) 0.94
d-Amphetamine as a releaser or reuptake inhibitor of biogenic amines in synaptosomes. Eur J Pharmacol (1975) 0.94
d-amphetamine and the release of 3H-norepinephrine from synaptosomes. Eur J Pharmacol (1974) 0.93
Cytokine regulation of astrocyte function: in-vitro studies using cells from the human brain. Int J Dev Neurosci (1995) 0.93
Modulation of non-N-methyl-D-aspartate receptors in cultured cerebellar granule cells. J Neurochem (1990) 0.93
Release-enhancing glycine-dependent presynaptic NMDA receptors exist on noradrenergic terminals of hippocampus. Eur J Pharmacol (1990) 0.93
Human immunodeficiency virus type-1 Tat protein induces nuclear factor (NF)-kappaB activation and oxidative stress in microglial cultures by independent mechanisms. J Neurochem (2001) 0.92
Interferon-gamma and nitric oxide down-regulate lipopolysaccharide-induced prostanoid production in cultured rat microglial cells by inhibiting cyclooxygenase-2 expression. J Neurochem (1996) 0.91
Cholecystokinin release mediated by 5-HT3 receptors in rat cerebral cortex and nucleus accumbens. Br J Pharmacol (1991) 0.91
Increased CSF levels of prostaglandin E(2) in variant Creutzfeldt-Jakob disease. Neurology (2002) 0.91
In vivo activation of N-methyl-D-aspartate receptors in the rat hippocampus increases prostaglandin E(2) extracellular levels and triggers lipid peroxidation through cyclooxygenase-mediated mechanisms. J Neurochem (2002) 0.91
N-methyl-D-aspartic acid (NMDA) and non-NMDA receptors regulating hippocampal norepinephrine release. I. Location on axon terminals and pharmacological characterization. J Pharmacol Exp Ther (1992) 0.91
Cerebrospinal fluid isoprostane shows oxidative stress in patients with multiple sclerosis. Neurology (1999) 0.90
Modulation of the function of presynaptic alpha7 and non-alpha7 nicotinic receptors by the tryptophan metabolites, 5-hydroxyindole and kynurenate in mouse brain. Br J Pharmacol (2006) 0.90
Cerebellar astroglial cells in primary culture: expression of different morphological appearances and different ability to take up [3H]D-aspartate and [3H]GABA. Brain Res (1983) 0.90
Ion channels in rat microglia and their different sensitivity to lipopolysaccharide and interferon-gamma. J Neurosci Res (1995) 0.90
Studies on [3H]GABA and endogenous GABA release in rat cerebral cortex suggest the presence of autoreceptors of the GABAB type. Eur J Pharmacol (1987) 0.90
Different estimates of tissue extracellular space using [carboxyl-14C]-inulin from different sources. Anal Biochem (1969) 0.90
Serotonin autoreceptor in rat hippocampus: pharmacological characterization as a subtype of the 5-HT1 receptor. Naunyn Schmiedebergs Arch Pharmacol (1986) 0.89
Control of cerebral metabolite levels. I. Amino acid uptake and levels in various species. Arch Biochem Biophys (1967) 0.89
Pathogenesis of atherosclerosis and the role of 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitors. Am J Cardiol (1995) 0.89